Impact of Metronidazole Resistance on the Eradication of Helicobacter pylori

References

• Coghlan J G, Humphries H, Dooley C, Keane C, Gilligan D, McKenna D, Sweeney E, O'Morain C. Campylobacter pylori and recurrence of duodenal ulcers: a 12 month follow-up study. Lancet 1987; 2: 1109–1111
   PubMed Web of Science ®Google Scholar
• Marshall B J, Goodwin C S, Warren J R, Murray R, Blincow E D, Blackbourn S J, Philips M, Waters T E, Sanderson C R. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1441
   PubMed Web of Science ®Google Scholar
• Borody T, Cole P, Noonan S, Morgan A, Lenne J, Hyland L, Brandl S, Borody E G, George L L. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431–435
   PubMed Web of Science ®Google Scholar
• Rauws E AJ, Tytgat G NJ. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233–1235
   PubMed Web of Science ®Google Scholar
• George L L, Borody T J, Andrews P, Devine M, Moore-Jones D, Walton M, Brandl S. Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990; 153: 145–149
   PubMed Web of Science ®Google Scholar
• Graham D Y, Lew G M, Klein P D, Evans D G, Evans D J, Saeed Z A, Malaty H M. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized controlled study. Ann Intern Med 1992; 116: 705–708
   PubMed Web of Science ®Google Scholar
• Bayerdörffer E, Ottenjann R. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol Suppl 1988; 142: 93–100
   PubMedGoogle Scholar
• Glupczynski Y, Burette A. Drug therapy for Helico-bacter pylori infection: problems and pitfalls. Am J Gastroenterol 1990; 85: 1545–1551
   PubMed Web of Science ®Google Scholar
• Graham D Y, Klein P D, Opekun A R, Smith K E, Polasani R R, Evans D J, Evans D G, Alpert L C, Michaletz P A, Yoshimura H H, Adam E. In vivo susceptibility of Campylobacter pylori. Am J Gastroenterol 1989; 84: 233–238
   PubMed Web of Science ®Google Scholar
• Rauws E AJ. Therapeutic attempts at eradication of Campylobacter pylori. Eur J Gastroenterol Hepatol 1989; 1: 34–41
   Google Scholar
• O'Riordan T, Mathai E, Tobin E, McKenna D, Keane C, Sweeney E, O'Morain C. Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate. Gut 1990; 31: 999–1002
   PubMed Web of Science ®Google Scholar
• Bell G D, Weil J, Powell K, Jobson R, Harrison G, Gant P W, Jones P H, Owen R J, Moreno M, Trowell J E. Helicobacter pylori treated with combinations of tripotassium dicitrato bismuthate and metronidazole: efficacy of different treatment regimens and some observations on the emergence of metronidazole resistance. Eur J Gastroenterol Hepatol 1991; 3: 819–822
   Web of Science ®Google Scholar
• Van Caekenberghe D L, Breyssens J. In vitro synergistic activity between bismuth subcitrate and various anti-microbial agents against Campylobacter pyloridis (C. pylori). Antimicrob Agents Chemother 1987; 31: 1429–1430
   PubMed Web of Science ®Google Scholar
• Veldhuyzen van Zanten S JO, Goldie J, Hollingsworth J, Siletti C, Richardson H, Hunt R H. Secretion of intravenously administered ampicillin, erythromycin and metronidazole in gastric juice. Implications for management of Helicobacter pylori. J Clin Pathol 1992; 45: 225–227
   PubMedGoogle Scholar
• Lamouliatte H, Cayla R, Meyer M, Demotes-Moinard F, Vincon G, Quentin-Nourry C, Vialette G, Megraud F. Pharmacokinetics of oral and intravenous amoxillin in human gastric mucosa [Abstract]. Gastroenterology 1992; 102: A107
   Google Scholar
• Rautelin H, Seppala K, Renkonen O V, Vainio U, Kosunen T U. Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother 1992; 36: 163–166
   PubMed Web of Science ®Google Scholar
• Burette A, Glupczynski Y, De Prez C. Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 817–823
   Web of Science ®Google Scholar
• Goodwin C S, Marshall B J, Blincow E D, Wilson D H, Blackbourn S, Phillips M. Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. J Clin Pathol 1988; 41: 207–210
   PubMed Web of Science ®Google Scholar
• Logan R PH, Gummett P A, Misiewicz J J, Karim Q N, Walker M M, Baron J H. One week eradication regimen for Helico-bacier pylori. Lancet 1991; 338: 1249–1252
   PubMed Web of Science ®Google Scholar
• De Koster E, Nyst J F, Deprez C, Glupczynski Y, Otero J, Denis P, Van Geel J, Buset M, De Reuck M, Deltenre M. Towards a coherent HP treatment strategy [Abstract]. Itai J Gastroenterol 1991; 23(Suppl 2)103
   Google Scholar
• Bell G D, Powell K, Burridge S M, Pallecaros A, Jones P H, Gant P W, Harrison G, Trowell J E. Experience with “triple” anti-Helicobacter pylori eradication therapy: side-effects and the importance of testing the pretreatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427–435
   PubMed Web of Science ®Google Scholar
• Weil J, Bell G D, Morden A, Harrison G, Gant P W, Jones P H, Trowell J E. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther 1990; 4: 651–657
   PubMed Web of Science ®Google Scholar
• McColl K EL, Fullarton G M, Chittajalu R, El Nujumi A M, MacDonald A MI, Dahill S W, Hilditch T E. Plasma gastrin, daytime intragastric pH and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects. Scand J Gastroenterol 1991; 26: 339–346
   PubMed Web of Science ®Google Scholar
• Borody T J, George L L, Brandl S, Andrews P, Lenne J, Moore-Jones D, Devine M, Walton M. Helicobacter pylori eradication with doxycycline-metronidazole bismuth subcitrate tripletherapy. Scand J Gastroenterol 1992; 27: 281–284
   PubMed Web of Science ®Google Scholar
• McNulty C AM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. Gastroenterol Clin Bio 1989; 13: 96B–100B
   Google Scholar
• Graham D Y, Lew G M, Malaty H M, Evans D G, Evans D J, Klein P D, Alpert L C, Genta R M. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493–496
   PubMed Web of Science ®Google Scholar
• Borody T J, Brandl S, Andrews P, Jankiewicz E, Ostapowicz N H. Helicobacter pylori eradication failure (EF)-further treatment possibilities [Abstract]. Gastroenterology 1992; 102
   Google Scholar
• Glupczynski Y. Metronidazole resistance in Helicobacter pylori: results of the second multicenter in vitro study [Abstract]. Ital J Gastroenterol 1991; 23(Suppl 2)107
   PubMedGoogle Scholar
• Glupczynski Y, Burette A, De Koster E, Nyst J F, Deltenre M, Cadranel S, Bordeaux L, De Vos D. Metronidazole resistance in Helicobacter pylori [Letter]. Lancet 1990; 335: 976–977
   PubMed Web of Science ®Google Scholar
• Becx M CJM, Janssen A JHM, Clasener H AL, de Koning R W. Metronidazole resistant Helicobacter pylori [Letter]. Lancet 1990; 335: 539–540
   PubMed Web of Science ®Google Scholar
• Weil J, Bell G D, Powell K, Jobson R, Trowell J E, Gant P, Jones P H. Helicobacter pylori and metronidazole resistance [Letter]. Lancet 1990; 336: 1445
   PubMed Web of Science ®Google Scholar
• Cederbrant G, Kahlmeter G, Ljungh Å. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J Antimicrob Chemother 1992; 29: 115–120
   PubMed Web of Science ®Google Scholar
• Tytgat G NJ, Axon A TR, Dixon M F, Graham D Y, Lee A, Marshall B J. Helicobacter pylori: causal agent in peptic ulcer disease? Working party report from World Congress of Gastroenterology 1990. Blackwell Scientific Publications., Sydney. Oxford 1990; 36–45
   Google Scholar
• Bayerdörffer E, Mannes G A, Sommer A, Hochter W, Weingart J, Hatz R, Lehn N, Ruckdeschel G, Dirschedl P, Stolte M. High dose omeprazole combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992; 4: 697–702
   Web of Science ®Google Scholar
• Logan R PH, Gummett P A, Hegarthy B T, Walker M M, Baron J H, Misiewicz J J. Clarithromycin and omeprazole for Helicobacter pylori [Letter]. Lancet 1992; 340: 239
   PubMed Web of Science ®Google Scholar